Each ml contains Fluorometholone 0.1% w/v and Tobramycin 0.3% w/v Ophthalmic Solution.

Flurisone T Eye Drops combine Fluorometholone, a corticosteroid, with Tobramycin, a broad-spectrum aminoglycoside antibiotic, to provide effective management of steroid-responsive inflammatory ocular conditions associated with superficial bacterial infection or where there is a risk of bacterial infection. The formulation helps reduce inflammation, redness, pain, and swelling while controlling susceptible bacterial pathogens.

Flurisone T Eye Drops are indicated for the treatment of steroid-responsive inflammatory ocular conditions where corticosteroid therapy is indicated and superficial bacterial ocular infection exists or there is a risk of bacterial ocular infection.

Fluorometholone is a synthetic ophthalmic corticosteroid that suppresses the inflammatory response by inducing lipocortin proteins, which inhibit phospholipase A2, thereby reducing the production of inflammatory mediators such as prostaglandins and leukotrienes. Tobramycin is a broad-spectrum aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, resulting in bacterial cell death. It is active against a wide range of gram-positive and gram-negative ophthalmic pathogens. Together, these agents provide simultaneous anti-inflammatory and antibacterial effects for appropriate ocular conditions.

Instill one drop into the conjunctival sac of the affected eye(s) two to four times daily, or as directed by the physician. In chronic conditions, treatment should be discontinued gradually by reducing the frequency of application. Therapy should not be discontinued prematurely.

Flurisone T Eye Drops are contraindicated in patients with known hypersensitivity to Fluorometholone, Tobramycin, or any component of the formulation. They are also contraindicated in most viral diseases of the cornea and conjunctiva, mycobacterial infections of the eye, and fungal ocular infections.